Zur Kurzanzeige

Binding of the Human 14-3-3 Isoforms to Distinct Sites in the Leucine-Rich Repeat Kinase 2

dc.date.accessioned2020-05-29T07:00:56Z
dc.date.available2020-05-29T07:00:56Z
dc.date.issued2020-04-07
dc.identifierdoi:10.17170/kobra-202005291309
dc.identifier.urihttp://hdl.handle.net/123456789/11576
dc.description.sponsorshipGefördert durch den Publikationsfonds der Universität Kassel
dc.language.isoeng
dc.rightsNamensnennung 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectLRRK2eng
dc.subject14-3-3 proteinseng
dc.subjectisoform specificityeng
dc.subjectParkinson’s diseaseeng
dc.subjectphosphorylationeng
dc.subject.ddc540
dc.subject.ddc570
dc.subject.ddc610
dc.titleBinding of the Human 14-3-3 Isoforms to Distinct Sites in the Leucine-Rich Repeat Kinase 2eng
dc.typeAufsatz
dcterms.abstractProteins of the 14-3-3 family are well known modulators of the leucine-rich repeat kinase 2 (LRRK2) regulating kinase activity, cellular localization, and ubiquitylation. Although binding between those proteins has been investigated, a comparative study of all human 14-3-3 isoforms interacting with LRRK2 is lacking so far. In a comprehensive approach, we quantitatively analyzed the interaction between the seven human 14-3-3 isoforms and LRRK2-derived peptides covering both, reported and putative 14-3-3 binding sites. We observed that phosphorylation is an absolute prerequisite for 14-3-3 binding and generated binding patterns of 14-3-3 isoforms to interact with peptides derived from the N-terminal phosphorylation cluster (S910 and S935), the Roc domain (S1444) and the C-terminus. The tested 14-3-3 binding sites in LRRK2 preferentially were recognized by the isoforms γ and η, whereas the isoforms ϵ and especially σ showed the weakest or no binding. Interestingly, the possible pathogenic mutation Q930R in LRRK2 drastically increases binding affinity to a peptide encompassing pS935. We then identified the autophosphorylation site T2524 as a so far not described 14-3-3 binding site at the very C-terminus of LRRK2. Binding affinities of all seven 14-3-3 isoforms were quantified for all three binding regions with pS1444 displaying the highest affinity of all measured singly phosphorylated peptides. The strongest binding was detected for the combined phosphosites S910 and S935, suggesting that avidity effects are important for high affinity interaction between 14-3-3 proteins and LRRK2.eng
dcterms.accessRightsopen access
dcterms.creatorManschwetus, Jascha Tobias
dcterms.creatorWallbott, Maximilian
dcterms.creatorFachinger, Alexandra
dcterms.creatorObergruber, Claudia
dcterms.creatorPautz, Sabine
dcterms.creatorBertinetti, Daniela
dcterms.creatorSchmidt, Sven H.
dcterms.creatorHerberg, Friedrich W.
dc.relation.doidoi:10.3389/fnins.2020.00302
dc.subject.swdParkinson-Krankheitger
dc.subject.swdProtein-Serin-Threonin-Kinasenger
dc.subject.swdPhosphorylierungger
dc.type.versionpublishedVersion
dcterms.source.identifierISSN 1662-453X
dcterms.source.issueVolume 14
dcterms.source.journalFrontiers in Neuroscienceeng
dcterms.source.pageinfoArticle 302
dcterms.source.volume2020
kup.iskupfalse


Dateien zu dieser Ressource

Thumbnail
Name:
license_rdf
Größe:
908Bytes
Format:
application/rdf+xml
Öffnen
Thumbnail
Name:
fnins_14_00302.pdf
Größe:
1.795Mb
Format:
PDF
Öffnen

Das Dokument erscheint in:

Zur Kurzanzeige

Namensnennung 4.0 International
Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: Namensnennung 4.0 International